Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli
- 1 May 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 131, 263-274
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology of China (2013CB834501)
- the Science and Technology Commission of Shanghai Municipality (13NM1400200)
- National Natural Science Foundation of China (21102017)
- China Postdoctoral Association
This publication has 63 references indexed in Scilit:
- Hearing loss in Mexican children treated with cisplatinInternational Journal of Pediatric Otorhinolaryngology, 2014
- Platinum anticancer drugs. From serendipity to rational designAnnales Pharmaceutiques Françaises, 2011
- Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcomaCancer, 2011
- Activating Platinum Anticancer Complexes with Visible LightAngewandte Chemie International Edition, 2010
- Nongenomic Effects of Cisplatin: Acute Inhibition of Mechanosensitive Transporters and Channels without Actin RemodelingCancer Research, 2010
- The status of platinum anticancer drugs in the clinic and in clinical trialsDalton Transactions, 2010
- The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner earBritish Journal of Pharmacology, 2007
- CisplatinAnnals of Internal Medicine, 1984
- Haemolytic anaemia after cisplatin treatment.BMJ, 1981
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969